BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKesson
Citi
Harvard Business School
US Army
Farmers Insurance
AstraZeneca
Boehringer Ingelheim
Chinese Patent Office
Chubb

Generated: January 22, 2018

DrugPatentWatch Database Preview

Finasteride - Generic Drug Details

« Back to Dashboard

What are the generic sources for finasteride and what is the scope of finasteride patent protection?

Finasteride
is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Actavis Totowa, Actavis Totowa Teva, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla Ltd, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Gedeon Richter Usa, Hetero Labs Ltd Iii, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sun Pharma Global, Teva, Zydus Pharms Usa Inc, and Merck, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Finasteride has six patent family members in five countries.

There are fourteen drug master file entries for finasteride. Forty-one suppliers are listed for this compound.
Pharmacology for finasteride
Medical Subject Heading (MeSH) Categories for finasteride

US Patents and Regulatory Information for finasteride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva FINASTERIDE finasteride TABLET;ORAL 076905-001 Nov 5, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms FINASTERIDE finasteride TABLET;ORAL 076340-001 Jun 19, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global FINASTERIDE finasteride TABLET;ORAL 090508-001 Jul 1, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Inc FINASTERIDE finasteride TABLET;ORAL 076436-001 Jul 28, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alkem Labs Ltd FINASTERIDE finasteride TABLET;ORAL 207750-001 Jan 6, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Totowa FINASTERIDE finasteride TABLET;ORAL 078371-001 Nov 5, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hetero Labs Ltd Iii FINASTERIDE finasteride TABLET;ORAL 090061-001 Jun 7, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global FINASTERIDE finasteride TABLET;ORAL 090507-001 Aug 16, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Cipla Ltd FINASTERIDE finasteride TABLET;ORAL 077335-001 Nov 20, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for finasteride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Subscribe ➤ Subscribe
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
UBS
Harvard Business School
Argus Health
US Army
Baxter
Mallinckrodt
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot